HEMGENIX FOR DUMMIES

Number of suitable sufferers: CDEC discussed the uncertainty in the quantity of individuals with moderately severe to critical hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical industry experts consulted by CADTH indicated that some sufferers who will be classified as obtaining moderate or average condition could possibly have